Leerink Boosts PT on Alere (ALR) to $56; Doesn't See Regulatory Issues, Stronger Bid Above Abbott (ABT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Abbott Laboratories (NYSE: ABT) | Delayed: 100.51 -1.94 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.45 | 52 Week High | $46.38 | |||
| Open | $101.31 | 52 Week Low | $36.00 | |||
| Day High | $106.35 | P/E | 67.01 | |||
| Day Low | $97.67 | EPS | $1.50 | |||
| Volume | 22,909,533 | |||||
| ALERE, Inc. (NASDAQ: ALR) | Delayed: 1.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $54.13 | |||
| Open | $10.12 | 52 Week Low | $31.47 | |||
| Day High | $1.32 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $-1.13 | |||
| Volume | 7 | |||||
